当前位置:首页 - 行情中心 - 泰格医药(300347) - 财务分析 - 利润表

泰格医药

(300347)

  

流通市值:257.59亿  总市值:393.11亿
流通股本:5.60亿   总股本:8.55亿

利润表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、营业总收入5,791,528,067.343,707,560,174.21,801,473,935.036,832,800,615.35
  营业收入5,791,528,067.343,707,560,174.21,801,473,935.036,832,800,615.35
二、营业总成本5,216,682,770.593,348,891,613.171,644,573,250.456,312,645,254.48
  营业成本4,207,600,108.352,687,044,293.791,321,581,301.064,959,606,315.77
  税金及附加28,542,226.517,215,270.858,559,140.9834,929,024.09
  销售费用174,154,972.01109,736,247.0256,191,158.6234,658,095.13
  管理费用534,025,131.59353,246,010.52173,425,810.23725,906,444.89
  研发费用206,608,033.85139,365,219.4362,655,948.12257,643,569.77
  财务费用65,752,298.2942,284,571.5622,159,891.4699,901,804.83
  其中:利息费用-32,816,589.51-90,559,390.82
  其中:利息收入-7,477,747.22-15,126,062.26
三、其他经营收益
  加:公允价值变动收益-596,976,684.29-443,323,794.17195,035,877.1542,256,274.39
  加:投资收益29,328,488.54-2,431,886.7536,660,390.11433,815,899.7
  资产处置收益-16,069,206.08-18,083,068.74-463,466.463,650,548.27
  资产减值损失(新)-5,174,622.28-3,598,601.99-572,928.54-38,961,326.65
  信用减值损失(新)-3,489,082.082,721,374.18-2,488,564.141,917,920.09
  其他收益29,722,892.8527,398,667.5520,766,535.5346,585,292.33
四、营业利润12,187,083.41-78,648,748.89405,838,528.231,009,419,969
  加:营业外收入1,622,950.47595,900.99133,522.922,238,748.93
  减:营业外支出3,909,561.952,162,460.0427,742.78,443,597.94
五、利润总额9,900,471.93-80,215,307.94405,944,308.451,003,215,119.99
  减:所得税费用133,953,129.29105,256,011.8375,860,662.83198,158,945.47
六、净利润-124,052,657.36-185,471,319.77330,083,645.62805,056,174.52
(一)按经营持续性分类
  持续经营净利润-124,052,657.36-185,471,319.77330,083,645.62805,056,174.52
(二)按所有权归属分类
  归属于母公司股东的净利润-272,048,633.37-413,159,500.4149,043,121.13887,890,076.31
  少数股东损益147,995,976.01227,688,180.64281,040,524.49-82,833,901.79
  扣除非经常损益后的净利润450,066,412.63277,720,545.46120,394,081.64355,078,814.5
七、每股收益
  (一)基本每股收益-0.32-0.480.061.04
  (二)稀释每股收益-0.32-0.480.061.04
八、其他综合收益-172,607,574.25-176,529,004.82-87,366,018.26-53,653,137.05
  归属于母公司股东的其他综合收益-138,385,640.62-134,769,091.18-63,703,960.36-42,027,176.87
九、综合收益总额-296,660,231.61-362,000,324.59242,717,627.36751,403,037.47
  归属于母公司股东的综合收益总额-410,434,273.99-547,928,591.59-14,660,839.23845,862,899.44
  归属于少数股东的综合收益总额113,774,042.38185,928,267257,378,466.59-94,459,861.97
公告日期2026-10-302026-08-292026-04-292026-03-31
审计意见(境内)标准无保留意见
TOP↑